Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1

Interventions

AZD 6244 12trametinib 4mirdametinib 2fludarabine 2Lasers, Solid-State 2Inhalation 2Deoxycholic Acid 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1omipalisib 1lorlatinib 1fludarabine phosphate 1encorafenib 1dabrafenib 1cabozantinib 1binimetinib 1abemaciclib 1Waiting Lists 1Vincristine 1Specimen Handling 1Sirolimus 1Rituximab 1Radiation 1Polidocanol 1N-monoacetylcystine 1Melphalan 1Magnetic Resonance Spectroscopy 1Lovastatin 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Polidocanol × 1 year × Clear all
NCT06132165 2025-11-21

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Massachusetts General Hospital

Phase 1 Completed
13 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡